首页> 外文期刊>Hospital pharmacy. >Perioperative Intravenous Acetaminophen in Pediatric Tonsillectomies
【24h】

Perioperative Intravenous Acetaminophen in Pediatric Tonsillectomies

机译:围手术期静脉内乙酰氨基酚在儿科扁桃体切除术中

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: This study investigated the effect of perioperative intravenous (IV) acetaminophen on opioid requirements in pediatric patients undergoing tonsillectomy at a single center. Methods: This retrospective chart review included patients who were less than 18 years old and underwent an outpatient tonsillectomy procedure. Patients who received non-Food and Drug Administration (FDA)-approved dosing of IV acetaminophen, without documented weights, and on chronic pain medications at the time of the procedure were excluded. The primary outcome was opioid requirements postoperatively prior to discharge measured as morphine equivalents per kilogram. Descriptive statistics were used to compare differences between groups. A multivariate analysis was performed, accounting for differences between groups in baseline and procedural characteristics. Results: In total, 157 patients were included in this study, of whom 55 had received IV acetaminophen and 102 had not. The average IV acetaminophen dose for was 14.5 mg/kg for patients weighing less than 50 kg (n = 22); the remaining patients received the maximum I g dose. Patients who received IV acetaminophen were less likely to be administered postoperative opiates as compared with those did not (45.5% vs 63.7%, odds ratio = 0.48, P = .036). There was a trend toward a decrease in total amount of opiates administered with IV acetaminophen (0 vs 0.033 Mg/kg, P = .61). After adjusting for age and documented pain assessment, IV acetaminophen administration remained a significant factor for postoperative opiate administration. Conclusions: Perioperative administration of IV acetaminophen was associated with less frequent administration of symptom-directed opiates in pediatric tonsillectomies. This finding indicates that the agent may have an opioid-sparing effect in this patient population.
机译:目的:本研究研究了围手术期静脉注射(IV)乙酰氨基酚对单个中心扁桃体切除术治疗术患者的阿片类药物的影响。方法:此回顾性图表综述包括少于18岁的患者,并经历了门诊扁桃体切除术手术。接受非食品和药物管理局(FDA)的患者 - 批准IV乙酰氨基酚的剂量,没有记录的重量,并排除了程序时的慢性疼痛药物。在放电之前术后主要结果是每公斤用吗啡当量测量的阿片类药物要求。描述性统计数据用于比较组之间的差异。进行多变量分析,核算基线和程序特征中的群体之间的差异。结果:总共包括157名患者,其中55名接受了IV乙酰氨基酚,102名没有。对于体重小于50kg的患者,平均IV乙酰氨基酚剂量为14.5mg / kg(n = 22);其余患者接受了最大的I g剂量。与没有(45.5%vs 63.7%,差值= 0.48,P = 0.036)相比,接受乙酰乙酰苯酚的患者术后不太可能施用术后鸦片蛋白。在乙酰乙酰氨基酚施用的氨基酸胺的总量下降(0 vs 0.033mg / kg,p = .61),存在趋势。调整年龄和记录的疼痛评估后,IV乙酰氨基酚给药仍然是术后阿片类药物的重要因素。结论:围手术期施用IV乙酰氨基酚与小儿扁桃体切除术中较少频繁的症状导向蛋白质施用。该发现表明该试剂可以在该患者群体中具有阿片类药物缓解效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号